Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Indrani Talukder

1PUBLICATIONS

22CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|May 20, 2025

Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.

Stephen L DeAngelo, Liang Zhao, Sofia Dziechciarz

Pageof 1

Frequent Collaborators

1 joint publications

Stephen L DeAngelo

1 joint publications

Liang Zhao

1 joint publications

Sofia Dziechciarz

1 joint publications

Myungsun Shin

1 joint publications

Sumeet Solanki

1 joint publications

Andrii Balia

1 joint publications

Marwa O El-Derany

1 joint publications

Cristina Castillo

1 joint publications

Yao Qin

1 joint publications

Nupur K Das

Frequent Collaborators

1 joint publications

Stephen L DeAngelo

1 joint publications

Liang Zhao

1 joint publications

Sofia Dziechciarz

1 joint publications

Myungsun Shin

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos